DrugPatentWatch Database Preview
Forest Labs Inc Company Profile
What is the competitive landscape for FOREST LABS INC, and what generic alternatives to FOREST LABS INC drugs are available?
There are seven US patents protecting FOREST LABS INC drugs.
There are thirty-five patent family members on FOREST LABS INC drugs in twenty-five countries.
Summary for Forest Labs Inc
| International Patents: | 35 |
| US Patents: | 7 |
| Tradenames: | 3 |
| Ingredients: | 1 |
| NDAs: | 3 |
Drugs and US Patents for Forest Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Forest Labs Inc | ZENPEP | pancrelipase (amylase;lipase;protease) | CAPSULE, DELAYED RELEASE;ORAL | 022210-005 | Jun 15, 2011 | RX | Yes | No | 8,562,978 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Forest Labs Inc | ZENPEP | pancrelipase (amylase;lipase;protease) | CAPSULE, DELAYED RELEASE;ORAL | 022210-005 | Jun 15, 2011 | RX | Yes | No | 8,562,981 | ➤ Sign Up | ➤ Sign Up | ||||
| Forest Labs Inc | ZENPEP | pancrelipase (amylase;lipase;protease) | CAPSULE, DELAYED RELEASE;ORAL | 022210-007 | Mar 25, 2014 | RX | Yes | No | 8,562,980 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Forest Labs Inc | ZENPEP | pancrelipase (amylase;lipase;protease) | CAPSULE, DELAYED RELEASE;ORAL | 022210-001 | Aug 27, 2009 | RX | Yes | No | 8,246,950 | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Non-Orange Book US Patents for Forest Labs Inc
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 8,293,229 | Methods of producing stable pancreatic enzyme compositions | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Forest Labs Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Costa Rica | 20140422 | ➤ Sign Up |
| China | 103933555 | ➤ Sign Up |
| Canada | 2677989 | ➤ Sign Up |
| European Patent Office | 2079445 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
